CINDY HONG: Open Payments
NPI 1689262461 · TOMBALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$906 in 40 payments from 12 companies in 2025. Trend: 2023 $855 · 2024 $765 · 2025 $906
Food & beverage: $906
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $205 |
| Novo Nordisk Inc | 2 | $187 |
| Amgen Inc. | 2 | $103 |
| Exact Sciences Corporation | 4 | $97 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $69 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
Products named: Wegovy, Cologuard Collection Kit, VRAYLAR, REPATHA, Kerendia, UBRELVY, AIRSUPRA, JARDIANCE.
Industry payments across TX — which companies pay providers there.
